Kodiak Sciences Inc. (KOD) Financial Statements
Industry: Biological Products, (No Diagnostic Substances)
In fiscal 2025, Kodiak Sciences reported revenue of $0. Net income was -$230.0M, or -$4.32 per diluted share. Operating activities generated -$136.0M of cash, leaving -$136.5M of free cash flow. At fiscal year end, Kodiak Sciences held $351.5M in total assets against $194.2M in total liabilities, including $209.9M of cash and equivalents.
Open the full interactive Kodiak Sciences financials → Quarterly statements, key ratios, valuation history and price charts.
Kodiak Sciences Key Stats
| Share Price | $91.63 |
|---|---|
| Market Cap | $5.74B |
| 52-Week Range | $11.60 – $99.87 |
| Shares Outstanding | 62.6 million (basic, 2026 Q2) |
Kodiak Sciences Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$136.0M | -$267.1M | -$341.4M | -$277.3M | -$186.8M | -$234.4M |
| Pre-Tax Income | -$133.1M | -$266.9M | $333.8M | $260.4M | -$176.2M | -$229.9M |
| Income Tax | $14,000 | $74,000 | $33,000 | $33,000 | $20,000 | $52,000 |
| Net Income | -$133.1M | -$267.0M | -$333.8M | -$260.5M | -$176.2M | -$230.0M |
| Diluted EPS | -$2.91 | -$5.16 | -$6.39 | -$4.97 | -$3.35 | -$4.32 |
Kodiak Sciences Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Net Income | -$61.5M | -$56.7M | -$58.2M | -$65.6M |
| Diluted EPS | -$1.16 | -$1.07 | -$0.94 | -$1.05 |
Kodiak Sciences Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $944.4M | $731.5M | $190.4M | $285.5M | $168.1M | $209.9M |
| Current Assets | $972.0M | $734.8M | $486.0M | $289.3M | $171.9M | $214.8M |
| Total Assets | $1.07B | $904.2M | $666.6M | $479.4M | $335.6M | $351.5M |
| Current Liabilities | $31.4M | $64.7M | $52.5M | $41.7M | $25.6M | $45.5M |
| Total Liabilities | $206.6M | $240.9M | $230.5M | $213.6M | $185.3M | $194.2M |
| Shareholders' Equity | $860.8M | $663.3M | $436.2M | $265.8M | $150.3M | $157.4M |
Kodiak Sciences Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$83.4M | -$182.3M | -$206.5M | -$154.2M | -$117.3M | -$136.0M |
| Cash From Investing | $104.8M | -$38.8M | -$336.5M | $249.2M | -$755,000 | -$506,000 |
| Cash From Financing | $717.4M | $8.2M | $1.9M | $31,000 | $501,000 | $178.3M |
| Free Cash Flow | -$87.2M | -$199.3M | -$243.5M | -$195.5M | -$117.7M | -$136.5M |
Figures from Kodiak Sciences' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Kodiak Sciences financials page for every line item.
Kodiak Sciences Company Profile
| Ticker | KOD |
|---|---|
| Exchange | Nasdaq |
| Industry | Biological Products, (No Diagnostic Substances) |
| Headquarters | Palo Alto, California |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001468748 |
Frequently Asked Questions
What was Kodiak Sciences' revenue in fiscal 2025?
Kodiak Sciences (KOD) reported revenue of $0 for fiscal 2025.
What is Kodiak Sciences' annual revenue history?
Kodiak Sciences' annual revenue by fiscal year: 2020: $0; 2021: $0; 2022: $0; 2023: $0; 2024: $0; 2025: $0.
What was Kodiak Sciences' net income in fiscal 2025?
Kodiak Sciences reported net income of -$230.0M for fiscal 2025.
What was Kodiak Sciences' earnings per share (EPS) in fiscal 2025?
Kodiak Sciences' diluted EPS was -$4.32 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Kodiak Sciences generate in fiscal 2025?
Kodiak Sciences generated -$136.5M of free cash flow in fiscal 2025.
What was Kodiak Sciences' revenue last quarter?
In its most recent reported quarter (2026 Q2), Kodiak Sciences reported revenue of $0.
How many shares of Kodiak Sciences are outstanding?
Kodiak Sciences reported a weighted average of 62.6 million basic shares outstanding in 2026 Q2.
What is Kodiak Sciences' market cap?
Based on its latest closing price, Kodiak Sciences (KOD) has a market capitalization of about $5.74B.
When does Kodiak Sciences' fiscal year end?
Kodiak Sciences' fiscal year end, as registered with the SEC, is December 31.
Where is Kodiak Sciences headquartered?
Kodiak Sciences lists its business address in Palo Alto, California in its SEC filings.
Kodiak Sciences Competitors & Similar Companies
See all 136 Biological Products, (No Diagnostic Substances) companies →